Multidisciplinary Approach to Reduce Cardiovascular Health Disparities
NCT06168968 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 400
Last updated 2024-11-05
Summary
The goal of this observational study is to investigate the potential differences in thrombogenicity between black and white patients admitted with atherothrombotic events including acute coronary syndrome, multi-vessel coronary disease, and ischemic stroke.
Participants will engage in laboratory testing and health outcome assessments.
Conditions
- Acute Coronary Syndrome
- Multi Vessel Coronary Artery Disease
- Ischemic Stroke
Interventions
- BEHAVIORAL
-
Life and Medication Recommendations
Based on obtained subjective and objective data from patient-filled questionnaire and laboratory testing respectively, lifestyle and medication recommendations will be provided for secondary prevention of cardiovascular and cerebrovascular diseases
Sponsors & Collaborators
-
University of Maryland
collaborator OTHER -
LifeBridge Health
lead OTHER
Principal Investigators
-
Jenna Brager, PhD · LifeBridge Health
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-02-06
- Primary Completion
- 2025-06-30
- Completion
- 2025-12-31
Countries
- United States
Study Locations
More Related Trials
-
A Randomized, Double Blind Study To Compare The Effects Of Olmesartan Medoxomil Versus Placebo In Patients With Established Atherosclerosis
NCT00382213 ·Status: COMPLETED ·Phase: PHASE3
-
A Trial of Low-dose Adjunctive alTeplase During prIMary PCI
NCT02257294 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase II Study of the Safety and Efficacy of MPSK3169A in Patients With Coronary Heart Disease or High Risk of Coronary Heart Disease
NCT01609140 ·Status: COMPLETED ·Phase: PHASE2
-
A Research Study to Look at the Effect of Ziltivekimab on Plaque in the Blood Vessels of the Heart, Compared to Placebo, in People With a Heart Attack
NCT07301034 ·Status: RECRUITING ·Phase: PHASE3
-
Double-Blind, Randomized, Placebo-Controlled Trial of MLN1202 on C-Reactive Protein Levels in Patients With Risk Factors for Cardiovascular Disease
NCT00715169 ·Status: COMPLETED ·Phase: PHASE2
-
Carotid Atherosclerosis: MEtformin for Insulin ResistAnce Study
NCT00723307 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of RVX000222 on Time to Major Adverse Cardiovascular Events in High-Risk T2DM Subjects With CAD
NCT02586155 ·Status: COMPLETED ·Phase: PHASE3
-
Multicenter Trial to Evaluate the Effect of Dapagliflozin on the Incidence of Cardiovascular Events
NCT01730534 ·Status: COMPLETED ·Phase: PHASE3
-
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
NCT00799903 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Evaluate the Effects of MEDI6012 on Apolipoprotein B100 Metabolism
NCT03773172 ·Status: TERMINATED ·Phase: PHASE2
-
A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome
NCT05754957 ·Status: COMPLETED ·Phase: PHASE3
-
Multiple Ascending Doses of MEDI6012 in Subjects With Stable Atherosclerotic Cardiovascular Disease
NCT03004638 ·Status: COMPLETED ·Phase: PHASE2
-
ESCALATion of Medical Therapy Following Multimodality Plaque Evaluation in High-risk Chronic Coronary Syndromes
NCT06469528 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Vascular Aging: The Link That Bridges Age to Atherosclerosis (The VALIDATE Study)
NCT00246493 ·Status: TERMINATED
-
A Study of How MK-0736 Affects Arterial Plaque (0736-006)(TERMINATED)
NCT00679055 ·Status: TERMINATED ·Phase: PHASE1
-
Stop Atherosclerosis in Native Diabetics Study
NCT00147251 ·Status: COMPLETED ·Phase: PHASE4
-
Treatment of ACuTe Coronary Syndromes With Low-dose colchICine
NCT06215989 ·Status: RECRUITING ·Phase: NA
-
A STUDY TO LEARN HOW THE STUDY MEDICINE CALLED PF-07293893 AFFECTS MUSCLE BIOMARKERS OF HEALTHY ADULTS
NCT06413693 ·Status: COMPLETED ·Phase: PHASE1
-
Cardiovascular Risk Reduction Study (Reduction in Recurrent Major CV Disease Events)
NCT01327846 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Ticagrelor on Adenosine-Induced Coronary Flow Reserve in Patients With Microvascular Angina
NCT02284048 ·Status: UNKNOWN ·Phase: PHASE4
-
A Proof of Concept Study to Determine the Local Delivery and Efficacy of Nanocort
NCT01647685 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
PRE-EMPT: Prospective RandomizEd Evaluation and Management of Premature aTherosclerosis
NCT07232069 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Proof of Mechanism Study of MLN1202 on Atherosclerotic Inflammation in Participants With Stable Atherosclerotic Cardiovascular Disease
NCT02388971 ·Status: WITHDRAWN ·Phase: PHASE2
-
Treatment of Patients With Atherosclerotic Disease With Methotrexate-associated to LDL Like Nanoparticles
NCT04616872 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Arterial Disease Multifactorial Intervention Trial (ADMIT)
NCT00000539 ·Status: COMPLETED ·Phase: PHASE3